Postoperative radiotherapy for cutaneous melanoma of the head and neck region
K. Kian Ang(The University of Texas MD Anderson Cancer Center), Robert M. Byers(The University of Texas MD Anderson Cancer Center), Chul S. Ha(The University of Texas MD Anderson Cancer Center), Randal S. Weber(The University of Texas MD Anderson Cancer Center), William H. Morrison(The University of Texas MD Anderson Cancer Center), Robert A. Frankenthaler(The University of Texas MD Anderson Cancer Center), Lester J. Peters(Fermi National Accelerator Laboratory), Adam S. Garden(The University of Texas MD Anderson Cancer Center), Helmuth Goepfert(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
November 1, 1994
Cited by 201
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
|Journal of Clinical Oncology|2014|830
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806